Diaphorina citri psyllid: psy10024

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------7
MRKVVCLDQIRPAIPNRWHACKDLHLVLKIMQECWYPVATARPTALRIKKTIASIILSDQAVSYPDVIS
ccEEEEcccccccccccccccHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHcccccccccccc
MRKVVCLDQIRPAIPNRWHACKDLHLVLKIMQECWYPVATARPTALRIKKTIASIILSDQA********
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MRKVVCLDQIRPAIPNRWHACKDLHLVLKIMQECWYPVATARPTALRIKKTIASIILSDQAVSYPDVIS

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
TGF-beta receptor type-1 Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.confidentP80204
TGF-beta receptor type-1 Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.confidentQ5CD18
TGF-beta receptor type-1 Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.confidentQ64729

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0048185 [MF]activin bindingprobableGO:0032403, GO:0003674, GO:0005488, GO:0005515
GO:0005524 [MF]ATP bindingprobableGO:0043168, GO:0003674, GO:0005488, GO:0030554, GO:0035639, GO:0097159, GO:1901363, GO:0043167, GO:0036094, GO:0032553, GO:0032559, GO:0001883, GO:0032549, GO:0032555, GO:0017076, GO:0000166, GO:0032550, GO:1901265, GO:0001882
GO:0005025 [MF]transforming growth factor beta receptor activity, type IprobableGO:0038023, GO:0060089, GO:0016773, GO:0016772, GO:0003824, GO:0016301, GO:0016740, GO:0005024, GO:0004675, GO:0004674, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0004672, GO:0019199
GO:0001501 [BP]skeletal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:1901164 [BP]negative regulation of trophoblast cell migrationprobableGO:2000242, GO:2000241, GO:0050789, GO:0065007, GO:2000145, GO:1901163, GO:0030336, GO:0030334, GO:0050793, GO:0051271, GO:0050794, GO:0043900, GO:0051270, GO:0008150, GO:0051239, GO:0048519, GO:0032879, GO:0040013, GO:0040012, GO:2000026, GO:2000146, GO:0048523
GO:0051291 [BP]protein heterooligomerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0016043, GO:0065003, GO:0044085, GO:0008150, GO:0071840
GO:0046332 [MF]SMAD bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0048568 [BP]embryonic organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0070724 [CC]BMP receptor complexprobableGO:0043234, GO:0043235, GO:0032991, GO:0044459, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005887, GO:0005886, GO:0044425, GO:0031226, GO:0031224
GO:0003230 [BP]cardiac atrium developmentprobableGO:0003205, GO:0007507, GO:0032501, GO:0044707, GO:0072358, GO:0048856, GO:0044767, GO:0072359, GO:0048513, GO:0008150, GO:0048731, GO:0032502, GO:0007275, GO:0044699
GO:0009411 [BP]response to UVprobableGO:0008150, GO:0009314, GO:0050896, GO:0009416, GO:0009628
GO:0050431 [MF]transforming growth factor beta bindingprobableGO:0019955, GO:0003674, GO:0019838, GO:0005515, GO:0005488
GO:0032330 [BP]regulation of chondrocyte differentiationprobableGO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0061035, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0060284 [BP]regulation of cell developmentprobableGO:0050793, GO:0050794, GO:0045595, GO:0008150, GO:0065007, GO:0050789
GO:0016324 [CC]apical plasma membraneprobableGO:0045177, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0016323 [CC]basolateral plasma membraneprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0018107 [BP]peptidyl-threonine phosphorylationprobableGO:0044267, GO:0006468, GO:0009987, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0018210, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0018105 [BP]peptidyl-serine phosphorylationprobableGO:0044267, GO:0006468, GO:0018209, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0045446 [BP]endothelial cell differentiationprobableGO:0032502, GO:0060429, GO:0003158, GO:0030154, GO:0009888, GO:0008150, GO:0044763, GO:0048869, GO:0030855, GO:0009987, GO:0044699, GO:0048856
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0043062 [BP]extracellular structure organizationprobableGO:0009987, GO:0016043, GO:0008150, GO:0044699, GO:0044763, GO:0071840
GO:0051272 [BP]positive regulation of cellular component movementprobableGO:0051270, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0032879, GO:0050789, GO:0048522
GO:0010596 [BP]negative regulation of endothelial cell migrationprobableGO:0030336, GO:0040013, GO:0030334, GO:0010594, GO:0010632, GO:0010633, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0051270, GO:2000145, GO:0051239, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0001837 [BP]epithelial to mesenchymal transitionprobableGO:0030154, GO:0048468, GO:0009653, GO:0007275, GO:0044699, GO:0014031, GO:0048864, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0048513, GO:0071840, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0048863, GO:0044763, GO:0060485, GO:0000904, GO:0044707, GO:0048856, GO:0048731
GO:0000082 [BP]G1/S transition of mitotic cell cycleprobableGO:0051325, GO:0044699, GO:0000278, GO:0008150, GO:0009987, GO:0051329, GO:0044770, GO:0044772, GO:0022402, GO:0022403, GO:0044763, GO:0007049
GO:0007162 [BP]negative regulation of cell adhesionprobableGO:0030155, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0007179 [BP]transforming growth factor beta receptor signaling pathwayprobableGO:0007166, GO:0023052, GO:0007165, GO:0070887, GO:0007167, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0070848, GO:0071310, GO:0065007, GO:0071559, GO:0071495, GO:0009987, GO:0050794, GO:0042221, GO:0044763, GO:0007154, GO:0010033, GO:0007178, GO:0044700, GO:0071363, GO:0050896, GO:0071560, GO:0008150
GO:0048179 [CC]activin receptor complexprobableGO:0043234, GO:0043235, GO:0032991, GO:0044459, GO:0016021, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005887, GO:0005886, GO:0044425, GO:0031226, GO:0031224
GO:0005901 [CC]caveolaprobableGO:0045121, GO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0004702 [MF]receptor signaling protein serine/threonine kinase activityprobableGO:0004674, GO:0016773, GO:0005057, GO:0003824, GO:0016301, GO:0060089, GO:0016740, GO:0003674, GO:0004871, GO:0004672, GO:0016772
GO:0001667 [BP]ameboidal cell migrationprobableGO:0040011, GO:0048870, GO:0009987, GO:0006928, GO:0051674, GO:0044763, GO:0008150, GO:0016477, GO:0051179, GO:0044699
GO:0009791 [BP]post-embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0008150, GO:0007275, GO:0044699
GO:0016361 [MF]activin receptor activity, type IprobableGO:0038023, GO:0060089, GO:0017002, GO:0016772, GO:0003824, GO:0016301, GO:0016740, GO:0004675, GO:0004674, GO:0004888, GO:0003674, GO:0004872, GO:0004871, GO:0004672, GO:0019199, GO:0016773
GO:0051336 [BP]regulation of hydrolase activityprobableGO:0019222, GO:0050790, GO:0008150, GO:0065007, GO:0065009, GO:0050789
GO:0009952 [BP]anterior/posterior pattern specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:0043010 [BP]camera-type eye developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0019899 [MF]enzyme bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0031396 [BP]regulation of protein ubiquitinationprobableGO:0032268, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0031323, GO:0050794, GO:0065007, GO:0031399, GO:0008150, GO:0050789
GO:0001525 [BP]angiogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0048646, GO:0048731, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0010862 [BP]positive regulation of pathway-restricted SMAD protein phosphorylationprobableGO:0019220, GO:0009893, GO:0019222, GO:0031325, GO:0048584, GO:0048583, GO:0023056, GO:0023051, GO:0010647, GO:0010646, GO:0050789, GO:0080090, GO:0010604, GO:0090100, GO:0009966, GO:0009967, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0090092, GO:0045937, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0060393, GO:0001932, GO:0001934, GO:0048522
GO:0030513 [BP]positive regulation of BMP signaling pathwayprobableGO:0090092, GO:0010646, GO:0090100, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0048522, GO:0050789, GO:0030510
GO:0030182 [BP]neuron differentiationprobableGO:0032502, GO:0048699, GO:0009987, GO:0044707, GO:0007399, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0048856
GO:0060037 [BP]pharyngeal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0048731, GO:0043009, GO:0007275, GO:0044699
GO:0009855 [BP]determination of bilateral symmetryprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0009799, GO:0007275, GO:0044699
GO:0043627 [BP]response to estrogen stimulusprobableGO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0048545, GO:0009725, GO:0042221, GO:0010033, GO:0014070
GO:2000017 [BP]positive regulation of determination of dorsal identityprobableGO:0051094, GO:0050793, GO:0051240, GO:2000015, GO:0008150, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0030500 [BP]regulation of bone mineralizationprobableGO:0050793, GO:0070167, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0030278, GO:0050789
GO:0060391 [BP]positive regulation of SMAD protein import into nucleusprobableGO:0033157, GO:0032388, GO:0060341, GO:0051049, GO:0032386, GO:0048584, GO:0048583, GO:0070201, GO:0023056, GO:0023051, GO:0010647, GO:0010646, GO:0051222, GO:0032880, GO:0051223, GO:0090100, GO:0009966, GO:0009967, GO:0050789, GO:0065007, GO:0048518, GO:0090092, GO:0051050, GO:0090316, GO:0050794, GO:0008150, GO:0042307, GO:0042306, GO:0032879, GO:1900180, GO:0060390, GO:0046824, GO:0046822, GO:0048522
GO:0022603 [BP]regulation of anatomical structure morphogenesisprobableGO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0032924 [BP]activin receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0090101 [BP]negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathwayprobableGO:0090092, GO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0023014 [BP]signal transduction by phosphorylationprobableGO:0044700, GO:0051716, GO:0008152, GO:0016310, GO:0050896, GO:0009987, GO:0044237, GO:0050794, GO:0008150, GO:0006796, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0006793, GO:0007154, GO:0050789, GO:0044699
GO:0005771 [CC]multivesicular bodyprobableGO:0005737, GO:0043231, GO:0043227, GO:0005770, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0005768, GO:0043226
GO:0005938 [CC]cell cortexprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0071944, GO:0044424
GO:0030509 [BP]BMP signaling pathwayprobableGO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0051716, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0010468, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0044763, GO:0051171, GO:2001141, GO:0007154, GO:0007178, GO:0044700, GO:0050896, GO:0051252, GO:0006355, GO:0010556, GO:0008150
GO:0001707 [BP]mesoderm formationprobableGO:0032502, GO:0048598, GO:0048856, GO:0001704, GO:0048332, GO:0007498, GO:0007369, GO:0009888, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0044699, GO:0048729, GO:0009653, GO:0007275, GO:0048646, GO:0044707
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0009986 [CC]cell surfaceprobableGO:0005575, GO:0044464, GO:0005623
GO:0072001 [BP]renal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0001655, GO:0048731, GO:0007275, GO:0044699
GO:0042118 [BP]endothelial cell activationprobableGO:0008150, GO:0001775, GO:0009987, GO:0044763, GO:0044699
GO:0045603 [BP]positive regulation of endothelial cell differentiationprobableGO:0051094, GO:0050793, GO:0045595, GO:0050794, GO:0045597, GO:0045601, GO:0065007, GO:0030856, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0030858, GO:0050789, GO:0048522
GO:0045602 [BP]negative regulation of endothelial cell differentiationprobableGO:0051093, GO:0050793, GO:0045595, GO:0050794, GO:0008150, GO:0045596, GO:0045601, GO:0065007, GO:0030856, GO:0030857, GO:0051239, GO:0048519, GO:2000026, GO:0050789, GO:0048523
GO:0003143 [BP]embryonic heart tube morphogenesisprobableGO:0032502, GO:0009790, GO:0072359, GO:0072358, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0048513, GO:0048729, GO:0060562, GO:0048598, GO:0009887, GO:0032501, GO:0035239, GO:0060429, GO:0035050, GO:0009888, GO:0003007, GO:0008150, GO:0035295, GO:0007507, GO:0044707, GO:0048856, GO:0044767, GO:0048731
GO:0035107 [BP]appendage morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0008150, GO:0048736, GO:0009653, GO:0007275, GO:0044699
GO:0030425 [CC]dendriteprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0051897 [BP]positive regulation of protein kinase B signaling cascadeprobableGO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0050789, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0051896, GO:0048522
GO:0070723 [BP]response to cholesterolprobableGO:1901700, GO:0033993, GO:0050896, GO:0008150, GO:0042221, GO:0036314, GO:0097305, GO:0010033, GO:0014070
GO:0001824 [BP]blastocyst developmentprobableGO:0032502, GO:0001701, GO:0044707, GO:0032501, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0060840 [BP]artery developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0060389 [BP]pathway-restricted SMAD protein phosphorylationprobableGO:0016310, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0044267, GO:0051716, GO:0044260, GO:0071704, GO:0065007, GO:0006468, GO:0044238, GO:0009987, GO:0006464, GO:0050794, GO:0043412, GO:0036211, GO:0044763, GO:0008152, GO:0007154, GO:0007178, GO:0044700, GO:0019538, GO:0050896, GO:0044237, GO:0043170, GO:0006796, GO:0006793, GO:0008150
GO:0046777 [BP]protein autophosphorylationprobableGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0065008 [BP]regulation of biological qualityprobableGO:0008150, GO:0065007
GO:0051130 [BP]positive regulation of cellular component organizationprobableGO:0051128, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522
GO:0001945 [BP]lymph vessel developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0008015 [BP]blood circulationprobableGO:0032501, GO:0044707, GO:0003013, GO:0008150, GO:0044699, GO:0003008
GO:0042060 [BP]wound healingprobableGO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0045165 [BP]cell fate commitmentprobableGO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0030308 [BP]negative regulation of cell growthprobableGO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0030307 [BP]positive regulation of cell growthprobableGO:0045927, GO:0040008, GO:0051128, GO:0001558, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522
GO:0022412 [BP]cellular process involved in reproduction in multicellular organismprobableGO:0032501, GO:0000003, GO:0032504, GO:0009987, GO:0048610, GO:0008150
GO:0007276 [BP]gamete generationprobableGO:0044702, GO:0000003, GO:0032504, GO:0019953, GO:0022414, GO:0032501, GO:0008150, GO:0044699, GO:0048609
GO:0010629 [BP]negative regulation of gene expressionprobableGO:0009892, GO:0019222, GO:0060255, GO:0050789, GO:0008150, GO:0065007, GO:0048519, GO:0010605, GO:0010468
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0000186 [BP]activation of MAPKK activityprobableGO:0019220, GO:0009893, GO:0019222, GO:0033674, GO:0031325, GO:0048583, GO:0032147, GO:0023051, GO:0010646, GO:0010627, GO:0050789, GO:0043085, GO:0043408, GO:0051347, GO:0010604, GO:0009966, GO:0010562, GO:0043549, GO:0051246, GO:0051247, GO:0032270, GO:0044093, GO:0031399, GO:0048518, GO:0065007, GO:0065009, GO:0050790, GO:0045937, GO:0060255, GO:0031323, GO:0045859, GO:0080090, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042325, GO:0042327, GO:0045860, GO:0031401, GO:0051338, GO:0001932, GO:0001934, GO:0048522
GO:0044087 [BP]regulation of cellular component biogenesisprobableGO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0051260 [BP]protein homooligomerizationprobableGO:0051259, GO:0022607, GO:0071822, GO:0070271, GO:0043933, GO:0006461, GO:0016043, GO:0065003, GO:0044085, GO:0008150, GO:0071840
GO:0005923 [CC]tight junctionprobableGO:0005575, GO:0070160, GO:0043296, GO:0030054, GO:0005911
GO:0048534 [BP]hematopoietic or lymphoid organ developmentprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0002520
GO:0001938 [BP]positive regulation of endothelial cell proliferationprobableGO:0008284, GO:0042127, GO:0050678, GO:0050679, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0001936, GO:0050789, GO:0048522
GO:0001937 [BP]negative regulation of endothelial cell proliferationprobableGO:0042127, GO:0008285, GO:0050678, GO:0050680, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523, GO:0001936

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3MDY, chain A
Confidence level:very confident
Coverage over the Query: 4-60
View the alignment between query and template
View the model in PyMOL